609 related articles for article (PubMed ID: 24665980)
21. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
[TBL] [Abstract][Full Text] [Related]
22. Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.
Estiú MC; Monte MJ; Rivas L; Moirón M; Gomez-Rodriguez L; Rodriguez-Bravo T; Marin JJ; Macias RI
Br J Clin Pharmacol; 2015 Feb; 79(2):316-29. PubMed ID: 25099365
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.
Serrano MA; Brites D; Larena MG; Monte MJ; Bravo MP; Oliveira N; Marin JJ
J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319
[TBL] [Abstract][Full Text] [Related]
24. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
Brites D; Rodrigues CM
J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
[TBL] [Abstract][Full Text] [Related]
25. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
Kawakita T; Parikh LI; Ramsey PS; Huang CC; Zeymo A; Fernandez M; Smith S; Iqbal SN
Am J Obstet Gynecol; 2015 Oct; 213(4):570.e1-8. PubMed ID: 26071912
[TBL] [Abstract][Full Text] [Related]
26. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
[TBL] [Abstract][Full Text] [Related]
27. Expression of urocortin and corticotrophin-releasing hormone receptor-2 in patients with intrahepatic cholestasis of pregnancy.
Zhou F; Zhang L; Sun Q; Wang XD
Placenta; 2014 Nov; 35(11):962-8. PubMed ID: 25172671
[TBL] [Abstract][Full Text] [Related]
28. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid.
Geenes V; Lövgren-Sandblom A; Benthin L; Lawrance D; Chambers J; Gurung V; Thornton J; Chappell L; Khan E; Dixon P; Marschall HU; Williamson C
PLoS One; 2014; 9(1):e83828. PubMed ID: 24421907
[TBL] [Abstract][Full Text] [Related]
29. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial.
Floreani A; Paternoster D; Melis A; Grella PV
Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):109-13. PubMed ID: 8841797
[TBL] [Abstract][Full Text] [Related]
30. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
Binder T; Salaj P; Zima T; Vítek L
J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.
Parízek A; Simják P; Cerný A; Sestinová A; Zdenková A; Hill M; Dusková M; Vlk R; Kokrdová Z; Koucký M; Vítek L
Ann Hepatol; 2016; 15(5):757-61. PubMed ID: 27493115
[TBL] [Abstract][Full Text] [Related]
32. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases.
Berkane N; Cocheton JJ; Brehier D; Merviel P; Wolf C; Lefèvre G; Uzan S
Acta Obstet Gynecol Scand; 2000 Nov; 79(11):941-6. PubMed ID: 11081677
[TBL] [Abstract][Full Text] [Related]
33. Ursodeoxycholic acid therapy in pregnant women with cholestasis.
Diaferia A; Nicastri PL; Tartagni M; Loizzi P; Iacovizzi C; Di Leo A
Int J Gynaecol Obstet; 1996 Feb; 52(2):133-40. PubMed ID: 8855091
[TBL] [Abstract][Full Text] [Related]
34. [Study on relationship between expression of familial intrahepatic cholestasis 1 mRNA in placenta and Intrahepatic cholestasis of pregnancy].
Xu Z; Ke JC; Xing AY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):430-3. PubMed ID: 18575333
[TBL] [Abstract][Full Text] [Related]
35. Role of sphingolipids in the pathogenesis of intrahepatic cholestasis.
Mikucka-Niczyporuk A; Pierzynski P; Lemancewicz A; Kosinski P; Charkiewicz K; Knas M; Kacerovsky M; Blachnio-Zabielska A; Laudanski P
Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106399. PubMed ID: 31733339
[TBL] [Abstract][Full Text] [Related]
36. Reduced plasma corticotropin-releasing hormone levels during late gestation in patients with intrahepatic cholestasis of pregnancy.
Huang G; Liu Z; He M; Wang X
Gynecol Obstet Invest; 2014; 78(3):168-72. PubMed ID: 25059485
[TBL] [Abstract][Full Text] [Related]
37. Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy.
Borges Manna L; Papacleovoulou G; Flaviani F; Pataia V; Qadri A; Abu-Hayyeh S; McIlvride S; Jansen E; Dixon P; Chambers J; Vazquez-Lopez M; Wahlström A; Kitaba N; Marschall HU; Godfrey KM; Lillycrop K; Williamson C
Sci Rep; 2020 Jun; 10(1):10361. PubMed ID: 32587408
[TBL] [Abstract][Full Text] [Related]
38. Bile acids evoke placental inflammation by activating Gpbar1/NF-κB pathway in intrahepatic cholestasis of pregnancy.
Zhang Y; Pan Y; Lin C; Zheng Y; Sun H; Zhang H; Wang J; Yuan M; Duan T; Du Q; Chen J
J Mol Cell Biol; 2016 Dec; 8(6):530-541. PubMed ID: 27402811
[TBL] [Abstract][Full Text] [Related]
39. Gradual dosing of ursodeoxycholic acid in mothers with intrahepatic cholestasis of pregnancy may improve composite neonatal outcome.
Hamud A; Cohen MJ; Hochner-Celnikier D; Bar-Oz B; Ackerman Z
Ann Hepatol; 2024; 29(3):101490. PubMed ID: 38403070
[TBL] [Abstract][Full Text] [Related]
40. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
